Vaxart logo

Vaxart share price today

(VXRT)

Vaxart share price is $0.62 & ₹52.69 as on 21 Dec 2024, 2.30 'hrs' IST

$0.62

▲

0.02

(2.7%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Vaxart share price in Dollar and Rupees. Guide to invest in Vaxart from India. Also see the sentimental analysis on Indian investors investing in Vaxart. Get details on the Indian mutual funds that are investing in Vaxart. Get Analyst recommendations and forecasts along with all the Vaxart's financials.

Vaxart share price movements

  • Today's Low: $0.59
    Today's High: $0.64

    Day's Volatility :7.41%

  • 52 Weeks Low: $0.52
    52 Weeks High: $1.54

    52 Weeks Volatility :66.23%

Vaxart Returns

PeriodVaxart IncSector (Health Care)Index (Russel 2000)
3 Months
-25.94%
-11.1%
0.0%
6 Months
-17.08%
-6.0%
0.0%
1 Year
5.99%
2.7%
0.0%
3 Years
-91.05%
0.6%
-19.7%

Vaxart Key Statistics

in dollars & INR

Previous Close
$0.6033
Open
$0.6
Today's High
$0.637249
Today's Low
$0.59
Market Capitalization
$137.2M
Today's Volume
$1.6M
52 Week High
$1.54
52 Week Low
$0.52
Revenue TTM
$13.9M
EBITDA
$-66.3M
Earnings Per Share (EPS)
$-0.4
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-91.66%

How to invest in Vaxart from India?

It is very easy for Indian residents to invest directly in Vaxart from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Vaxart stock in both Indian Rupees (INR) and US Dollars (USD). Search for Vaxart or VXRT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Vaxart or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Vaxart shares which would translate to 1.371 fractional shares of Vaxart as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Vaxart, in just a few clicks!

Returns in Vaxart for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Vaxart investment value today

Current value as on today

₹1,09,093

Returns

₹9,093

(+9.09%)

Returns from Vaxart Stock

₹6,897 (+6.9%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Vaxart

40%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Vaxart on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 40% more investors are searching Vaxart in the last 30 days versus the previous period.

Global Institutional Holdings in Vaxart

  • Sio Capital Management, LLC

    5.98%

  • Vanguard Group Inc

    4.43%

  • Millennium Management LLC

    1.74%

  • Geode Capital Management, LLC

    1.12%

  • BlackRock Inc

    0.78%

  • SILVERARC CAPITAL MANAGEMENT, LLC

    0.44%

Analyst Recommendation on Vaxart

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Vaxart(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Vaxart

What analysts predicted

Upside of 679.56%

Current:

$0.62

Target:

$4.83

Insights on Vaxart

  • Price Movement

    In the last 7 days, VXRT stock has moved up by 4.7%

  • VXRT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 32.2%

  • VXRT vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 114.1%

  • Price to Sales

    ForVXRT every $1 of sales, investors are willing to pay $7.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Vaxart Financials in INR & Dollars

FY18Y/Y Change
Revenue
$4.2M
↓ 53.27%
Net Income
$-18.0M
↓ 38.75%
Net Profit Margin
-432.96%
↓ 102.62%
FY19Y/Y Change
Revenue
$9.9M
↑ 137.12%
Net Income
$-18.6M
↑ 3.54%
Net Profit Margin
-189.06%
↑ 243.9%
FY20Y/Y Change
Revenue
$4.0M
↓ 58.97%
Net Income
$-32.2M
↑ 72.81%
Net Profit Margin
-796.34%
↓ 607.28%
FY21Y/Y Change
Revenue
$892.0K
↓ 77.95%
Net Income
$-70.5M
↑ 118.72%
Net Profit Margin
-7.9K%
↓ 7103.88%
FY22Y/Y Change
Revenue
$107.0K
↓ 88.0%
Net Income
$-107.8M
↑ 52.91%
Net Profit Margin
-100.7K%
↓ 92808.19%
FY23Y/Y Change
Revenue
$7.4M
↑ 6796.26%
Net Income
$-82.5M
↓ 23.47%
Net Profit Margin
-1.1K%
↑ 99590.85%
Q2 FY23Q/Q Change
Revenue
$1.4M
↑ 101.19%
Net Income
$-22.6M
↓ 10.3%
Net Profit Margin
-1.7K%
↑ 2063.91%
Q3 FY23Q/Q Change
Revenue
$446.0K
↓ 67.16%
Net Income
$-17.4M
↓ 22.84%
Net Profit Margin
-3.9K%
↓ 2240.82%
Q4 FY23Q/Q Change
Revenue
$3.2M
↑ 627.58%
Net Income
$-17.4M
↓ 0.14%
Net Profit Margin
-535.44%
↑ 3365.91%
Q1 FY24Q/Q Change
Revenue
$2.2M
↓ 32.79%
Net Income
$-24.4M
↑ 40.53%
Net Profit Margin
-1.1K%
↓ 584.09%
Q2 FY24Q/Q Change
Revenue
$6.4M
↑ 193.49%
Net Income
$-16.5M
↓ 32.56%
Net Profit Margin
-257.24%
↑ 862.29%
Q3 FY24Q/Q Change
Revenue
$4.9M
↓ 22.93%
Net Income
$-14.1M
↓ 14.49%
Net Profit Margin
-285.42%
↓ 28.18%
FY18Y/Y Change
Profit
$4.2M
↓ 53.27%
FY19Y/Y Change
Profit
$-4.7M
↓ 212.48%
FY20Y/Y Change
Profit
$-15.8M
↑ 238.11%
FY21Y/Y Change
Profit
$-47.9M
↑ 202.57%
FY22Y/Y Change
Profit
$-3.2M
↓ 93.4%
FY23Y/Y Change
Profit
$-60.8M
↑ 1822.88%
Q2 FY23Q/Q Change
Profit
$231.0K
↓ 157.46%
Q3 FY23Q/Q Change
Profit
$-754.0K
↓ 426.41%
Q4 FY23Q/Q Change
Profit
$2.0M
↓ 371.22%
Q1 FY24Q/Q Change
Profit
$1.1M
↓ 47.14%
Q2 FY24Q/Q Change
Profit
$-11.1M
↓ 1124.88%
Q3 FY24Q/Q Change
Profit
$4.9M
↓ 144.53%
FY18Y/Y Change
Operating Cash Flow
$-14.5M
↓ 51.51%
Investing Cash Flow
$26.2M
↑ 723.76%
Financing Cash Flow
$-1.7M
↑ 332.25%
FY19Y/Y Change
Operating Cash Flow
$-13.1M
↓ 10.02%
Investing Cash Flow
$-850.0K
↓ 103.24%
Financing Cash Flow
$16.0M
↓ 1023.08%
FY20Y/Y Change
Operating Cash Flow
$-23.8M
↑ 81.44%
Investing Cash Flow
$-1.2M
↑ 43.53%
Financing Cash Flow
$138.3M
↑ 766.63%
FY21Y/Y Change
Operating Cash Flow
$-59.8M
↑ 151.92%
Investing Cash Flow
$-49.1M
↑ 3924.34%
Financing Cash Flow
$125.8M
↓ 9.04%
FY22Y/Y Change
Operating Cash Flow
$-94.8M
↑ 58.41%
Investing Cash Flow
$-20.4M
↓ 58.42%
Financing Cash Flow
$17.5M
↓ 86.12%
Q2 FY23Q/Q Change
Operating Cash Flow
$-17.5M
↓ 28.57%
Investing Cash Flow
$-1.6M
↓ 106.22%
Financing Cash Flow
$13.9M
↑ 878.66%

Vaxart Technicals Summary

Sell

Neutral

Buy

Vaxart is currently in a neutral trading position according to technical analysis indicators.

Vaxart Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Vaxart Inc
Vaxart Inc
3.39%
-17.08%
5.99%
-91.05%
109.96%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.11%
13.66%
87.56%
Biontech Se
Biontech Se
4.48%
30.56%
7.36%
-56.46%
225.6%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.49%
30.99%
109.19%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-1.97%
78.33%
80.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Vaxart Inc
Vaxart Inc
NA
NA
NA
-0.4
-0.92
-0.4
NA
0.38
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Vaxart Inc
Vaxart Inc
Buy
$137.2M
109.96%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
87.56%
17.51
33.61%
Biontech Se
Biontech Se
Buy
$26.7B
225.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
109.19%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.59%
32.84
-4.51%

About Vaxart

since its founding in 2004, vaxart has pursued a vision of advancing vaccines—to make them as tablets rather than injections. the company’s proprietary oral vaccine delivery platform is suitable to deliver any recombinant vaccine, positioning vaxart to introduce oral forms of multiple vaccines in the rapidly growing global vaccines market.
Organization
Vaxart
Employees
109
CEO
Dr. Sean N. Tucker Ph.D.
Industry
Health Technology

Management People of Vaxart

NameTitle
Dr. Sean N. Tucker Ph.D.
Senior VP & Chief Scientific Officer
Dr. James F. Cummings M.D.
Chief Medical Officer
Mr. Steven Lo
President, CEO & Director
Mr. Phillip Eric Lee
CFO, Principal Financial Officer & Principal Accounting Officer
Dr. Raymond D. Stapleton Jr., Ph.D.
Chief Technology Officer
Mr. Edward B. Berg
Senior VP & General Counsel
Ms. Shaily Jaini Garg
Senior Vice President of Clinical Development & Project Management
Dr. Rajesh Kapoor Ph.D.
Senior Vice President of Quality

Important FAQs about investing in Vaxart from India :

What is Vaxart share price today?

Vaxart share price today stands at $0.62, Open: $0.60 ; Previous Close: $0.60 ; High: $0.64 ; Low: $0.59 ; 52 Week High: $1.54 ; 52 Week Low: $0.52. The stock opens at $0.60, after a previous close of $0.60. The stock reached a daily high of $0.64 and a low of $0.59, with a 52-week high of $1.54 and a 52-week low of $0.52.

Can Indians buy Vaxart shares?

Yes, Indians can invest in the Vaxart (VXRT) from India.

With INDmoney, you can buy Vaxart at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Vaxart at zero transaction cost.

How can I buy Vaxart shares from India?

It is very easy to buy Vaxart from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Vaxart be purchased?

Yes, you can buy fractional shares of Vaxart with INDmoney app.

What are the documents required to start investing in Vaxart stocks?

To start investing in Vaxart, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Vaxart

Today’s highest price of Vaxart (VXRT) is $0.64.

Today’s lowest price of Vaxart (VXRT) is $0.59.

What is today's market capitalisation of Vaxart

Today's market capitalisation of Vaxart VXRT is 137.2M

What is the 52 Week High and Low Range of Vaxart

  • 52 Week High

    $1.54

  • 52 Week Low

    $0.52

What are the historical returns of Vaxart?

  • 1 Month Returns

    3.39%

  • 3 Months Returns

    -17.08%

  • 1 Year Returns

    5.99%

  • 5 Years Returns

    109.96%

Who is the Chief Executive Officer (CEO) of Vaxart

Dr. Sean N. Tucker Ph.D. is the current Chief Executive Officer (CEO) of Vaxart.